Geron to Present at the 14th Annual Needham Healthcare Conference

MENLO PARK, Calif., April 7, 2015 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that John Scarlett, M.D., President and Chief Executive Officer, will present an overview of the company at the 14th Annual Needham Healthcare Conference in New York. The presentation is scheduled to occur on Tuesday, April 14, at 5:00 p.m. Eastern Time.

A live webcast of the presentation will be available through the Investor Relations pages of Geron's website or at http://wsw.com/webcast/needham71/gern/. Following the live presentation, the webcast will be archived and available for replay at the same address for a period of 30 days.

About Geron

Geron is a clinical stage biopharmaceutical company focused on the development of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit www.geron.com.

CONTACT: Kevin Eng, Ph.D.
         Investor and Media Relations
         650-473-7765
         [email protected]
         [email protected]

You May Also Be Interested In

• Needham Starts Faeth Therapeutics (FTH) at Buy
• Best Crypto Presale as the Market Cools: $BULLSKI Did Not Reprice
• Orum Therapeutics Announces U.S. FDA Clearance of an IND Application for ORM-1153, a Novel CD123-GSPT1 Degrader-Antibody Conjugate